NFKB1 and plasma cell myeloma: The non-canonical NF-κB pathway plays an important role in the pathogenesis of multiple myeloma, where it is constitutively activated by recurrent genetic alterations, including NIK amplifications and c-IAP1/2 and TRAF3 deletions [10,12,14].